Latest News and Press Releases
Want to stay updated on the latest news?
-
NEW YORK, March 11, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”) today reinforced how its strategic investment in PsyLabs strengthens its...
-
TORONTO and DAEJEON, South Korea, March 11, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Inc. (“Xanadu”), a leading photonic quantum computing company, has partnered with the Electronics and...
-
Parex Resources Enters into a Definitive Agreement to Acquire Frontera Energy’s Colombian E&P Assets
CALGARY, Alberta, March 10, 2026 (GLOBE NEWSWIRE) -- Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce that it has entered into a definitive agreement (the...
-
CALGARY, Alberta, March 10, 2026 (GLOBE NEWSWIRE) -- FLINT Corp. (“FLINT” or the "Company") (TSX: FLNT) today announced its results for the year ended December 31, 2025. All amounts are in Canadian...
-
OTTAWA, Ontario, March 10, 2026 (GLOBE NEWSWIRE) -- In an open letter addressed to Prime Minister Carney, Sandra Schwartz, National Executive Director of Canadian Parks and Wilderness Society...
-
New IDC Research Reveals Strong Appetite for AI Transformation Across the Profession, Alongside Calls for Standards, Safeguards and Oversight
-
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Esperoct Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. ...
-
OTTAWA, Ontario, March 10, 2026 (GLOBE NEWSWIRE) -- Telesat (Nasdaq and TSX: TSAT), one of the world’s largest and most innovative satellite operators, announced the acquisition of land in Estevan,...
-
– LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – –...
-
X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg dose compared with -10.4% for placebo...